Meet the Fellows Video Series

Meet the talented individuals who were awarded clinical and research fellowship funding from the Neuromuscular Disease Network for Canada (NMD4C), Muscular Dystrophy Canada (MDC), and the Canadian Society of Clinical Neurophysiologists (CSCN)!

 

The NMD4C and MDC are excited to share a new videos series featuring the five incredible fellows: Drs. Emanuela Pannia, Rebecca Robertson, Collin Luk, Marianne Nury and Alasdair Rathbone, recipients of the Neuromuscular Clinical and Research fellowship funding in 2022. Learn more about them as individuals, how they first became involved with NMD research, the people and experiences that have made a significant impact on their career, a piece of advice they would give others considering a career in NMD research, what excites them about their work, how they see their field advancing and ways we can better support patients.

In the second video of the Meet The Fellows video series we hear from Dr. Pannia, Dr. Robertson, Dr. Luk, Dr. Rathbone, and Dr. Nury on the people and experiences that have had a significant impact on their career. They also share their top piece of advice for anyone considering a career in neuromuscular disorder research or care.

Video #1 – Introduction


 

Video #2 – Who are the people and what are the experiences that have had a significant impact on their career?


Video #3 – What Excites You the Most About Your Work?


Thank you to the incredible donors and supporters who have made the funding of these five incredible individuals possible. We look forward to learning more about them as the series unfolds.

Meet the Fellows - now live

Read next...

Hope On The Horizon: Trials Treatments and Therapies for DMD, DM1 and MG

Hope on the Horizon: Trials, Treatments and Therapies for DMD, DM1 & MG

Nov 25-28, 2025 | Join us at Hope on the Horizon to learn more about the treatment and clinical trial landscape for Duchenne Muscular Dystrophy, Myotonic Dystrophy Type 1 and Myasthenia Gravis from key experts in the field!

Website - 2026 NMD4C Awards Now Open

2026 Awards Now Open for Nominations!

We’re proud to recognize outstanding achievements across the neuromuscular research community with our Three awards: Publication of the Year, Early Career Biomedical/Clinical Researchers of the Year.

AGAMREE (vamorolone) Approved treatment for DMD in Canada

A Milestone in Neuromuscular Care: AGAMREE® (vamorolone) Approved as the First Treatment for Duchenne Muscular Dystrophy in Canada

Health Canada has approved AGAMREE® (vamorolone), the first-ever treatment for Duchenne Muscular Dystrophy (DMD) in Canada. Patient Support Program opens for enrollment on October 10, 2025.